Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Kernan, W.; Viscoli, C.; Furie, K.; Young, L.; Inzucchi, S.; Gorman, M.; Guarino, P.; M. Lovejoy, Anne; Peduzzi, P.; Conwit, R.; Brass, L.; Schwartz, G.; Adams, H.; Berger, L.; Carolei, A.; Clark, W.; Coull, B.; Ford, G.; Kleindorfer, D.; O'leary, J.; Parsons, M.; Ringleb, P.; Sen, S.; Spence, J.; Tanné, D.; Wang, David; Winder, T.

doi:10.1056/NEJMoa1506930

Public

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Shared by NobleBlocks on Feb 17, 2016 • 12:00 AM UTC

Authors:

W. Kernan

C. Viscoli

K. Furie

Abstract

BACKGROUND Patients with ischemic stroke or transient ischemic attack (TIA) are at increased risk for future cardiovascular events despite current preventive therapies. The identification of insulin resistance as a risk factor for stroke and myocardial infarction raised the possibility that pioglita...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!